Carisma Therapeutics Inc. Stock
Our community identified positive and negative aspects for Carisma Therapeutics Inc. stock for the coming years. 1 users see the criterium "EBIT growth" as a plus for the Carisma Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Carisma Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Carisma Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | -2.020% | 13.033% | 33.509% | 24.413% | 33.836% | 124.292% | 13.384% |
| Evolus Inc | -2.830% | -3.196% | -28.136% | -68.120% | -22.202% | -56.954% | -9.130% |
| Champions Oncology Inc | -3.390% | -1.667% | 0.000% | -46.364% | 1.724% | 60.326% | -35.519% |